Utility of serum β2-microglobulin for prediction of kidney outcome among patients with biopsy-proven diabetic nephropathy.

Takayuki UemuraMasatoshi NishimotoMasahiro EriguchiHiroyuki TamakiHikari TasakiRiri FuruyamaFumihiro FukataTakaaki KosugiKatsuhiko MorimotoMasaru MatsuiKen-Ichi SamejimaKazuhiko Tsuruya

Published in: Diabetes, obesity & metabolism (2023)

Among patients with biopsy-proven DN, serum β2-MG was an independent predictor of KFRT and improved prediction performance. In addition to serum creatinine, serum β2-MG should probably be measured for DN.

Keyphrases

diabetic nephropathy
ultrasound guided